Xenon Pharmaceuticals Inc. Common Shares (NASDAQ: XENE) last traded at $36.44, up 0.77% on the session. The quote above updates while this page is open; the figures below are drawn from Xenon Pharmaceuticals Inc. Common Shares’s own filings and are restated only when a new one is published.
Xenon Pharmaceuticals Inc. Common Shares trades on NASDAQ under the ticker XENE. Its market capitalisation is $3.53 billion.
Valuation measures for Xenon Pharmaceuticals Inc. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.53B |
|---|---|
| Enterprise value | $3.46B |
| Price / book | 2.84 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Xenon Pharmaceuticals Inc. Common Shares's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$409.19M |
|---|
| EPS (TTM) | -$4.74 |
|---|
| Return on equity | -32.94% |
|---|
| Cash | $119.53M |
|---|
Range and volume for XENE over the past 52 weeks.
| 52-week high | $72.66 |
|---|---|
| 52-week low | $35.06 |
| Volume | 1.24M |
| Average volume | 1.42M |
| Previous close | $36.16 |
Invest a chosen dollar amount in Xenon Pharmaceuticals Inc. Common Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell XENE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.